Drugs / Bi-PegLyte
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT01398020 | Jul 2011 → Sep 2012 | — | University of British Columbia | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06298461 Comparator | Jul 2024 → Dec 2025 overdue | Crohn disease, ulcerative colitis | University of Manitoba | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bi-PegLyte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06298461 ↗ |
| Route | Oral | “Subjects will be asked to take 2L Bi-Peglyte and 15mg bisacodyl the day prior to procedure.” NCT01398020 ↗ |